logo
Wanted—and Needed—More Studies in Geriatric Lung Cancer Patients
Immunoinflammatory Mechanisms in Lung Cancer Development: Is Leptin a Mediator?
Nonsteroidal Anti-Inflammatory Drugs and Lung Cancer Risk: A Population-Based Case Control Study
Primary Lung Cancer Presenting with Gastrointestinal Tract Involvement: Clinicopathologic and Immunohistochemical Features in a Series of 18 Consecutive Cases
Endobronchial Ultrasonography in Bronchoscopic Occult Pulmonary Lesions
Clinical Characteristics and Survival of Patients with Surgically Resected, Incidentally Detected Lung Cancer
Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer
Gemcitabine versus Gemcitabine–Carboplatin for Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: A Prospective Randomized Phase II Study of the Hellenic Cooperative Oncology Group
Many Patients 80 Years and Older with Advanced Non-small Cell Lung Cancer (NSCLC) Can Tolerate Chemotherapy
Pemetrexed as Second-Line Treatment in Malignant Pleural Mesothelioma after Platinum-Based First-Line Treatment
A Phase II Study of Paclitaxel, Carboplatin, and Radiation with or without Surgery for Esophageal Cancer
Neoplastic Fever Caused by Lung Cancer
Amrubicin for the Treatment of Small Cell Lung Cancer: Does Effectiveness Cross the Pacific?
Orbital Metastasis as a Rare Form of Clinical Presentation of Non-small Cell Lung Cancer
Spontaneous Complete Remission of a Non-small Cell Lung Cancer Associated with Anti-Hu Antibody Syndrome